Positive correlations were identified between IL-1β expression and the infiltration of immunosuppressive MDSCs, as well as the expression of their chemoattractants in patients with K-ras-mutant lung adenocarcinoma (KM-LUAD), suggesting the therapeutic potential of IL-1β blockades. This evidence concerns the gene IL1B and lung adenocarcinoma.